Key result
HF disease management programs cut hospital readmissions ~25% while improving care quality and compliance.
Why the study?
Increasing life expectancy has elevated healthcare facility utilization and costs, warranting an examination of disease management program definitions, components, evidence, conditions for success, and implementation complexity using heart failure as an example.
Do disease management programs reduce hospital readmissions and improve care in patients with heart failure?
Systematic Review (n=23)
Do disease management programs reduce hospital readmissions and improve care in patients with heart failure?
Heart failure disease management programs are effective in improving patient compliance, reducing hospital readmissions, and lowering healthcare costs.
Answers are grounded in this paper and cite their sources.
Supports adoption of disease management programs in heart failure; confirms Level 1 trial evidence for improved outcomes.
Disease management programs (DMPs) have shown great potential for optimizing care of chronically ill patients, thereby improving health outcomes and patient satisfaction. This had led to an overall reduction in healthcare costs. Longer life expectancy has led to increased utilization of healthcare facilities, which may lead to a rise in costs. DMPs are an effective means of improving care and compliance and ultimately curbing inappropriate resource utilization. The present study reviews different definitions proposed for disease management, its components, the evidence behind it, and the conditions for success. It also examines heart failure management as an example of a DMP, exploring the complexity surrounding implementation of guideline-based approaches in patient care. A literature search on DMPs was conducted using PubMed, MEDLINE, and Google Scholar, including heart failure management programs from articles published from 2000 to 2020. This reviewed emphasized on the management of important biomarkers and cardiovascular indicators such as glycemic levels, urine output to improve efficacy of disease management programme during patient treatment. The review concluded that diseases like heart failure can be combat by improving the quality of care for patients and reducing the burden on the public healthcare system. Moreover, DMPs have proved to be an effective way of improving care and compliance with treatment.
No takes yet. Share an insight, caveat, or question.
Waleed AlHabeeb (2022) conducted a systematic review in Heart Failure (n=23). Disease Management Programs (DMPs) vs. Usual care was evaluated. Disease management programs for heart failure improve quality of care and treatment compliance, with a review of 18 trials showing a 25% reduction in the risk of hospital readmissions.
Synapse has enriched 10 related papers. Consider them for comparative context: